skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Design of Aminobenzothiazole Inhibitors of Rho Kinases 1 and 2 by Using Protein Kinase;#8197;A as a Structure Surrogate

Authors:
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;  [1]
  1. AbbVie
Publication Date:
Research Org.:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Org.:
INDUSTRY
OSTI Identifier:
1526052
Resource Type:
Journal Article
Journal Name:
ChemBioChem
Additional Journal Information:
Journal Volume: 19; Journal Issue: (6) ; 03, 2018
Country of Publication:
United States
Language:
ENGLISH

Citation Formats

Judge, Russell A., Vasudevan, Anil, Scott, Victoria E., Simler, Gricelda H., Pratt, Steve D., Namovic, Marian T., Putman, C. Brent, Aguirre, Ana, Stoll, Vincent S., Mamo, Mulugeta, Swann, Steven I., Cassar, Steven C., Faltynek, Connie R., Kage, Karen L., Boyce,, #8208, Rustay, Janel M., and Hobson, Adrian D. Design of Aminobenzothiazole Inhibitors of Rho Kinases 1 and 2 by Using Protein Kinase;#8197;A as a Structure Surrogate. United States: N. p., 2019. Web. doi:10.1002/cbic.201700547.
Judge, Russell A., Vasudevan, Anil, Scott, Victoria E., Simler, Gricelda H., Pratt, Steve D., Namovic, Marian T., Putman, C. Brent, Aguirre, Ana, Stoll, Vincent S., Mamo, Mulugeta, Swann, Steven I., Cassar, Steven C., Faltynek, Connie R., Kage, Karen L., Boyce,, #8208, Rustay, Janel M., & Hobson, Adrian D. Design of Aminobenzothiazole Inhibitors of Rho Kinases 1 and 2 by Using Protein Kinase;#8197;A as a Structure Surrogate. United States. doi:10.1002/cbic.201700547.
Judge, Russell A., Vasudevan, Anil, Scott, Victoria E., Simler, Gricelda H., Pratt, Steve D., Namovic, Marian T., Putman, C. Brent, Aguirre, Ana, Stoll, Vincent S., Mamo, Mulugeta, Swann, Steven I., Cassar, Steven C., Faltynek, Connie R., Kage, Karen L., Boyce,, #8208, Rustay, Janel M., and Hobson, Adrian D. Fri . "Design of Aminobenzothiazole Inhibitors of Rho Kinases 1 and 2 by Using Protein Kinase;#8197;A as a Structure Surrogate". United States. doi:10.1002/cbic.201700547.
@article{osti_1526052,
title = {Design of Aminobenzothiazole Inhibitors of Rho Kinases 1 and 2 by Using Protein Kinase;#8197;A as a Structure Surrogate},
author = {Judge, Russell A. and Vasudevan, Anil and Scott, Victoria E. and Simler, Gricelda H. and Pratt, Steve D. and Namovic, Marian T. and Putman, C. Brent and Aguirre, Ana and Stoll, Vincent S. and Mamo, Mulugeta and Swann, Steven I. and Cassar, Steven C. and Faltynek, Connie R. and Kage, Karen L. and Boyce, and #8208 and Rustay, Janel M. and Hobson, Adrian D.},
abstractNote = {},
doi = {10.1002/cbic.201700547},
journal = {ChemBioChem},
number = (6) ; 03, 2018,
volume = 19,
place = {United States},
year = {2019},
month = {6}
}

Works referenced in this record:

Specific Activation of LIM kinase 2 via Phosphorylation of Threonine 505 by ROCK, a Rho-dependent Protein Kinase
journal, October 2000

  • Sumi, Tomoyuki; Matsumoto, Kunio; Nakamura, Toshikazu
  • Journal of Biological Chemistry, Vol. 276, Issue 1
  • DOI: 10.1074/jbc.M007074200

Regulation of Myosin Phosphatase by Rho and Rho-Associated Kinase (Rho-Kinase)
journal, July 1996


Phosphorylation of Adducin by Rho-Kinase Plays a Crucial Role in Cell Motility
journal, April 1999

  • Fukata, Yuko; Oshiro, Noriko; Kinoshita, Nagatoki
  • The Journal of Cell Biology, Vol. 145, Issue 2
  • DOI: 10.1083/jcb.145.2.347

Rho kinase activates ezrin-radixin-moesin (ERM) proteins and mediates their function in cortical neuron growth, morphology and motility in vitro
journal, January 2006

  • Haas, Matilda A.; Vickers, James C.; Dickson, Tracey C.
  • Journal of Neuroscience Research, Vol. 85, Issue 1
  • DOI: 10.1002/jnr.21102

Physiological role of ROCKs in the cardiovascular system
journal, March 2006

  • Noma, Kensuke; Oyama, Naotsugu; Liao, James K.
  • American Journal of Physiology-Cell Physiology, Vol. 290, Issue 3
  • DOI: 10.1152/ajpcell.00459.2005

The p160 RhoA-binding kinase ROK alpha is a member of a kinase family and is involved in the reorganization of the cytoskeleton.
journal, October 1996

  • Leung, T.; Chen, X. Q.; Manser, E.
  • Molecular and Cellular Biology, Vol. 16, Issue 10
  • DOI: 10.1128/MCB.16.10.5313

ROCKs: multifunctional kinases in cell behaviour
journal, June 2003

  • Riento, Kirsi; Ridley, Anne J.
  • Nature Reviews Molecular Cell Biology, Vol. 4, Issue 6
  • DOI: 10.1038/nrm1128

Development of specific Rho-kinase inhibitors and their clinical application
journal, December 2005

  • Tamura, Masahiro; Nakao, Hiroshi; Yoshizaki, Hideo
  • Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, Vol. 1754, Issue 1-2
  • DOI: 10.1016/j.bbapap.2005.06.015

Fasudil, a Rho kinase inhibitor, drives mobilization of adult neural stem cells after hypoxia/reoxygenation injury in mice
journal, February 2010

  • Ding, Jing; Li, Qin-Ying; Yu, Jie-Zhong
  • Molecular and Cellular Neuroscience, Vol. 43, Issue 2
  • DOI: 10.1016/j.mcn.2009.11.001

The selective Rho-kinase inhibitor Fasudil is protective and therapeutic in experimental autoimmune encephalomyelitis
journal, November 2006


Rho kinase and hypertension
journal, December 2010


The Rho kinase inhibitor fasudil inhibits tumor progression in human and rat tumor models
journal, September 2006


Rho kinase, a promising drug target for neurological disorders
journal, May 2005

  • Mueller, Bernhard K.; Mack, Helmut; Teusch, Nicole
  • Nature Reviews Drug Discovery, Vol. 4, Issue 5
  • DOI: 10.1038/nrd1719

Rho-Associated Kinase Inhibitor Eye Drop (Ripasudil) Transiently Alters the Morphology of Corneal Endothelial Cells
journal, November 2015

  • Okumura, Naoki; Okazaki, Yugo; Inoue, Ryota
  • Investigative Opthalmology & Visual Science, Vol. 56, Issue 12
  • DOI: 10.1167/iovs.15-17887

Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma
journal, March 2018

  • Lin, Cheng-Wen; Sherman, Bryan; Moore, Lori A.
  • Journal of Ocular Pharmacology and Therapeutics, Vol. 34, Issue 1-2
  • DOI: 10.1089/jop.2017.0023

Ligand efficiency indices as guideposts for drug discovery
journal, April 2005


Linking Phenotype to Kinase: Identification of a Novel Benzoxaborole Hinge-Binding Motif for Kinase Inhibition and Development of High-Potency Rho Kinase Inhibitors
journal, September 2013

  • Akama, Tsutomu; Dong, Chen; Virtucio, Charlotte
  • Journal of Pharmacology and Experimental Therapeutics, Vol. 347, Issue 3
  • DOI: 10.1124/jpet.113.207662

Design, Synthesis, and Biological Evaluation of Novel, Highly Active Soft ROCK Inhibitors
journal, May 2015


Rho Kinase (ROCK) Inhibitors and Their Therapeutic Potential
journal, October 2015


Synthesis and evaluation of 4-(1-aminoalkyl)-N-(4-pyridyl)cyclohexanecarboxamides as Rho kinase inhibitors and neurite outgrowth promoters
journal, October 2004

  • Gingras, Karine; Avedissian, Hovsep; Thouin, Eryk
  • Bioorganic & Medicinal Chemistry Letters, Vol. 14, Issue 19
  • DOI: 10.1016/j.bmcl.2004.07.025

Design and synthesis of Rho kinase inhibitors (I)
journal, May 2004

  • Takami, Atsuya; Iwakubo, Masayuki; Okada, Yuji
  • Bioorganic & Medicinal Chemistry, Vol. 12, Issue 9
  • DOI: 10.1016/j.bmc.2004.02.025

A fast method of molecular shape comparison: A simple application of a Gaussian description of molecular shape
journal, November 1996


Benzothiazoles as Rho-associated kinase (ROCK-II) inhibitors
journal, December 2009


The development of benzimidazoles as selective rho kinase inhibitors
journal, March 2010

  • Sessions, E. Hampton; Smolinski, Michael; Wang, Bo
  • Bioorganic & Medicinal Chemistry Letters, Vol. 20, Issue 6
  • DOI: 10.1016/j.bmcl.2010.01.124

Quantitative assessment of tactile allodynia in the rat paw
journal, July 1994


A Simplified Up-Down Method (SUDO) for Measuring Mechanical Nociception in Rodents Using von Frey Filaments
journal, January 2014